HOME Top Market Reports Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry), Application (Biomarker & Drug Discovery, Nutrigenomics) & by Indication (Oncology, Cardiology) - Global Forecast to 2019

Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry), Application (Biomarker & Drug Discovery, Nutrigenomics) & by Indication (Oncology, Cardiology) - Global Forecast to 2019

By: marketsandmarkets.com
Publishing Date: June 2014
Report Code: BT 2550

 

  Speak to Analyst Enquiry Before Buying
 
purchase report
download pdf  request for customisation


Over the last decade, there has been a tremendous development in biochemistry and molecular biology which has had a positive impact on the overall growth of the metabolomics market. The market has witnessed the introduction of many advanced analytical equipment and data processing programs.

Growth in the market is driven by various factors such as the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and increasing need for toxicology testing. However, low adoption rates and data complexity inhibit the growth of the market to a certain extent. In addition to structural market drivers, there are strong geographic drivers as well for the growth of the market. The European market is increasingly becoming the growth center for the global market. The metabolomics market across Germany and the U.K. is slated to show a significant growth during the forecast period of 2014 to 2019. A higher CAGR in these markets is mainly attributed to the growing demand for personalized medicine, along with the increase in research funding from the respective governments and private investors.

The global metabolomics market is consolidated in nature, wherein the top five players account for more than 70%75% of the market share. However, there are many new players entering the market, which is increasing the competition and threatening the market share of existing players. In order to maintain their market share, leading players in the market are continuously developing new technologies and upgrading their existing technologies to enhance their product portfolio. The increasing competition is expected to drive innovation in the market, thereby helping the industry to overcome the existing challenges, and at the same time address the unmet needs of the market.

Scope of the Report

Metabolomics is the science of studying chemical processes concerning metabolites. It involves the use of various analytical techniques such as chromatography, spectrometry, nuclear magnetic resonance, and capillary electrophoresis. Metabolomics techniques generate a large amount of complex data which requires data processing and analysis software and other bioinformatics tools. The development of these advanced tools and equipment is the primary reason for the rapid growth in the metabolomics field. Metabolomics is now being extensively used in pharmaceutical and biotechnology industries for biomarker and drug discovery; pharmaceutical and biotechnology industries are expected to grow at a high rate in coming years, which is expected to boost the growth of the market. The nutrigenomics or nutritional genomics segment is also expected to have a positive effect on the growth of the market.

This research report categorizes the metabolomics market into the following segments:

  • By Technique
    • Separation Techniques
      • Gas Chromatography (GC)
      • Capillary Electrophoresis (CE)
      • High Performance Liquid Chromatography (HPLC)
      • Ultra Performance Liquid Chromatography (UPLC)
    • Detection Techniques
      • Nuclear Magnetic Resonance Spectroscopy (NMR)
      • Mass Spectrometry (MS)
      • Surface Based Mass Analysis
  • By Application
    • Biomarker Discovery
    • Drug Discovery/Drug Assessment
    • Toxicology Testing
    • Nutrigenomics
    • Others
  • By Indication
    • Oncology
    • Neurology
    • Cardiology
    • Others
  • By Geography
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • India
      • South Korea
      • Rest of Asia-Pacific
    • Rest of the World (RoW)
      • Latin America
      • Middle East

Table of Contents            
            
1 Introduction (Slide No. - 1)        
    1.1 Key Take-Aways          
    1.2 Report Description          
    1.3 Markets Covered          
    1.4 Stakeholders          
    1.5 Research Methodology          
    1.6 Market Size Estimation          
    1.7 Market crackdown and Data Triangulation          
    1.8 Market Forecasting Model          
    1.9 Key Data Point Taken from Secondary Sources          
    1.10 Key Data Point Taken from Primary Sources          
            
2 Executive Summary (Slide No. - 23)           
            
3 Premium Insights (Slide No. - 29)           
            
4 Market Overview (Slide No. - 35)          
    4.1 Introduction          
          4.1.1 Metabolomics Vs Metabonomics          
          4.1.2 Conceptual Approach in Metabolomics          
                  4.1.2.1 Target Analysis         
                  4.1.2.2 Metabolite Profiling         
                  4.1.2.3 Metabolomic Fingerprinting         
    4.2 Market Dynamics          
    4.3 Drivers          
          4.3.1 Research Funding and government support spurs the market growth           
          4.3.2 Biotechnology & Pharmaceutical Sectors Drive Metabolomics Research         
          4.3.3 Increasing demand for personalized medicine in healthcare industry          
          4.3.4 Increased Necessity for Toxicity Technologies         
    4.4 Restrains          
          4.4.1 Data Processing & Analysis         
          4.4.2 Low Adoption Rate         
    4.5 Opportunities          
          4.5.1 Untapped Emerging Market         
          4.5.2 Biomarker Discovery Services         
    4.6 Trends          
          4.6.1 Technological Advancements         
          4.6.2 Integration Of Research Universities With Market Players         
            
5 Technology Investment Potential (Slide No. - 51)           
    5.1 Introduction          
    5.2 Funding Bodies          
    5.3 Analysis of Potential Areas for Technology Investment using Strategic Evaluation           
    5.4 Technology Roadmap           
            
6 Metabolomics Market, by Technique (Slide No. - 66)           
    6.1  Separation Techniques          
          6.1.1  Gas Chromatography (GC)         
          6.1.2 Capillary Electrophoresis (CE)         
          6.1.3 High Performance Liquid Chromatography (HPLC)         
          6.1.4 Ultra Performance Liquid Chromatography (UPLC)         
    6.2 Detection Techniques          
          6.2.1 Nuclear Magnetic Resonance Spectroscopy (NMR)         
          6.2.2 Mass Spectrometry (MS)         
          6.2.3  Surface Based Mass Analysis           
            
7 Metabolomics Market, by Application (Slide No. - 85)           
    7.1 Biomarker Discovery          
    7.2 Drug Discovery/Drug Assessment          
    7.3 Toxicology Testing          
    7.4 Nutrigenomics          
    7.5 Others          
            
8 Metabolomics Market, by Indication (Slide No. - 101)           
    8.1 Oncology          
    8.2 Cardiology          
    8.3 Neurology          
    8.4 Others          
            
9 Metabolomics Market, by Geography (Slide No. - 124)           
    9.1  North America          
          9.1.1 U.S.         
          9.1.2 Canada         
    9.2  Europe          
          9.2.1  Germany         
          9.2.2 U.K.         
          9.2.3 France         
          9.2.4 Spain         
          9.2.5 Italy         
          9.2.6  Rest of Europe         
    9.3 Asia-Pacific          
          9.3.1  Japan         
          9.3.2  China         
          9.3.3 India         
          9.3.4  Rest of Asia-Pacific         
    9.4 Rest of the World (RoW)          
          9.4.1 Latin America         
          9.4.2 Middle East         
            
10 Competitive Landscape (Slide No. - 201)           
    10.1 New Product Launches          
    10.2 Agreements/Partnerships/Collaborations/Joint Ventures          
    10.3 Mergers and Acquisitions          
    10.4 Other Developments          
            
11 Company Profiles (Slide No. - 218)           
    11.1 Agilent Technologies           
          11.1.1 Business Overview         
          11.1.2 Products & Services         
          11.1.3 Key Financials         
          11.1.4 Growth Strategy         
          11.1.5 Recent Developments         
          11.1.6 SWOT Analysis         
          11.1.7 MNM View         
    11.2 Biocrates Life Sciences AG          
    11.3 Bruker Corporation           
    11.4 Danaher Corporation           
    11.5 Human Metabolomics Technologies, Inc.           
    11.6 LECO Corporation          
    11.7 Metabolon, Inc.           
    11.8 Shimadzu Corporation           
    11.9 Thermo Fisher Scientific Inc (Life Technologies + Prionics AG)          
    11.10 Waters Corporation           


List of Tables (80 Tables)

Table 1 Global Metabolomics Market, By Technique Market , by Geography, 20122019 ($Million)
Table 2 Global Metabolomics Seperation technique Market , by Technique, 20122019 ($Million)
Table 3 Global Metabolomics Separation technique Market , by Geography, 20122019 ($Million)
Table 4 Global Metabolomics Detection technique Market , by Geography, 20122019 ($Million)
Table 5 Global Gas Chromatography Market , by Geography, 20122019 ($Million)
Table 6 Global Capillary Electrophoresis Market , by Geography, 20122019 ($Million)
Table 7 Global High Performance liquid chromatography Market , by Geography, 20122019 ($Million)
Table 8 Global Ultra performance liquid chromatography Market , by Geography, 20122019 ($Million)
Table 9 Global Nuclear Magnetic Resonance Spectroscopy Market , by Geography, 20112018 ($Million)
Table 10 Global Mass Spectrometry Market, by Geography, 20122019 ($Million)
Table 11 Global Surface Based Mass Analysis Market , by Geography, 20122019 ($Million)
Table 12 Global Metabolomics Market , by Indication, 20122019 ($Million)
Table 13 Global Metabolomics Oncology Market , by Geography, 20122019 ($Million)
Table 14 Global Metabolomics Cardiology Market , by geography, 20122019 ($Million)
Table 15 Global Metabolomics Neurology Market , by Geography, 20122019 ($Million)
Table 16 Global Metabolomics Other Indications Market , by Geography, 20122019 ($Million)
Table 17 Global Metabolomics Market , by application, 20122019 ($Million)
Table 18 Global Metabolomics Biomarker Discovery Market , by Geography, 20122019 ($Million)
Table 19 Global Metabolomics Drug Discovery Market , by geography, 20122019 ($Million)
Table 20 Global Metabolomics Toxicology Testing Market , by Geography, 20122019 ($Million)
Table 21 Global Metabolomics Mutrigenomics Market , by Geography, 20122019 ($Million)
Table 22 Global Metabolomics Other Applications Market , by Geography, 20122019 ($Million)
Table 23 North America: Metabolomics Market, By Country , 20122019 ($Million)
Table 24 North America: Metabolomics Market, By technique, 20122019 ($Million)
Table 25 North America: Market, By application, 20122019 ($Million)
Table 26 North America: Metabolomics Market, By indication, 20122019 ($Million)
Table 27 U.S.: Metabolomics Market, By Technique, 20122019 ($Million)
Table 28 U.S.: Market, By Application, 20122019 ($Million)
Table 29 U.S.: Metabolomics Market, By Indication , 20122019 ($Million)
Table 30 Canada: Metabolomics Market, By Technique, 20122019 ($Million)
Table 31 Canada: Market, By Application, 20122019 ($Million)
Table 32 Canada: Market, By Indication, 20122019 ($Million)
Table 33 Europe: Metabolomics Market, By Country , 20122019 ($Million)
Table 34 Europe: Market, By Technique , 20122019 ($Million)
Table 35 Europe: Market, By application, 20122019 ($Million)
Table 36 Europe: Market, By Indication, 20122019 ($Million)
Table 37 U.K.: Metabolomics Mrket, By technique , 20122019 ($Million)
Table 38 U.K.: Metabolomics Market, By Application, 20122019 ($Million)
Table 39 U.K.: Market, By Indication, 20122019 ($Million)
Table 40 Germany: Metabolomics Market, By technique , 20122019 ($Million)
Table 41 Germany: Market, By Application, 20122019 ($Million)
Table 42 Germany: Market, By Indication, 2012-2019 ($Million)
Table 43 France: Market, By Technique, 2012- 2019($Million)
Table 44 France: Metabolomics Market, By Application, 2012- 2019($Million)
Table 45 France: Metabolomics Market, By Indication , 2012- 2019($Million)
Table 46 Italy: Metabolomics Market, By Technique , 2012- 2019($Million)
Table 47 Italy: Market, By Application , 2012- 2019($Million)
Table 48 Italy: Market, By Indication , 2012- 2019($Million)
Table 49 Spain: Metabolomics Market, By Technique , 2012- 2019($Million)
Table 50 Spain: Market, By Application , 2012- 2019($Million)
Table 51 Spain: Market, By Indication , 2012- 2019($Million)
Table 52 ROE: Metabolomics Market, By Technique , 2012- 2019($Million)
Table 53 ROE: Metabolomics Market, By Application , 2012- 2019($Million)
Table 54 ROE: Market, By Indication , 2012- 2019($Million)
Table 55 Asia_Pacific Metabolomics Market, By Country , 2012- 2019($Million)
Table 56 Asia_Pacific: Market, By Technique , 2012- 2019($Million)
Table 57 Asia_Pacific: Market, By Application , 2012- 2019($Million)
Table 58 Asia_Pacific: Metabolomics Market, By Indication , 2012- 2019($Million)
Table 59 Japan: Metabolomics Market, By Technique , 2012- 2019($Million)
Table 60 Japan: Market, By Application , 2012- 2019($Million)
Table 61 Japan: Market, By Indication , 2012- 2019($Million)
Table 62 China: Metabolomics Market, By Technique , 2012- 2019($Million)
Table 63 China: Market, By Application , 2012- 2019($Million)
Table 64 China: Metabolomics Market, By Indication , 2012- 2019($Million)
Table 65 India: Metabolomics Market, By Technique , 2012- 2019($Million)
Table 66 India: Market, By Application , 2012- 2019($Million)
Table 67 India: Market, By Indication , 2012- 2019($Million)
Table 68 RoAPAC: Metabolomics Market, By Technique , 2012- 2019($Million)
Table 69 RoAPAC: Metabolomics Market, By Application , 2012- 2019($Million)
Table 70 RoAPAC: Market, By Indication , 2012- 2019($Million)
Table 71 RoW: Metabolomics Market, By Country , 2012- 2019($Million)
Table 72 RoW: Market, By Technique , 2012- 2019($Million)
Table 73 RoW: Market, By Application , 2012- 2019($Million)
Table 74 RoW: Market, By Indication , 2012- 2019($Million)
Table 75 Latin America: Metabolomics Market, By Technique , 2012- 2019($Million)
Table 76 Latin America: Market, By Application , 2012- 2019($Million)
Table 77 Latin America: Market, By Indication , 2012- 2019($Million)
Table 78 Middle East: Metabolomics Market, By Technique , 2012- 2019($Million)
Table 79 Middle East: Market, By Application , 2012- 2019($Million)
Table 80 Middle East: Market, By Indication , 2012- 2019($Million)


List of Figures (7 Figures)
        
Figure 1 Research methodology       
Figure 2 Market Size Estimation Methodology       
Figure 3 DATA Triangulation Methodology       
Figure 4 Global Metabolomics Technique Market, 2014 VS. 2019 ($Milliion)       
Figure 5 Global Market for Companion Animals, 2013 VS. 2018 ($Milliion)       
Figure 6 Metabolomics Market: High-Growth Markets, 2013       
Figure 7 Market Dynamics of Global Market

The global metabolomics market was valued at $565 million in 2014 and is expected to grow at a high CAGR during the forecast period of 2014 to 2019. This market is mainly driven by the increase in government and private funding for metabolomics research and the growing demand for personalized medicine. Moreover, growth in the pharmaceutical and biotechnology industries is also expected to contribute to the growth of the market. However, the market growth will be restrained to an extent due to several factors such as low adoption rate of metabolomics, data complexity, and lack of skilled professionals.

The global market is segmented based on techniques, applications, indications, and geography. Based on techniques, the market is classified into Gas Chromatography, High Performance Liquid Chromatography (HPLC), Ultra Performance Liquid Chromatography (UPLC), Nuclear Magnetic Resonance Spectroscopy (NMR), Mass Spectrometry (MS), and Surface-based Mass Analysis. The metabolomics application market covers biomarker discovery, drug discovery/drug assessment, toxicology testing, nutrigenomics, and others. Furthermore, based on indications, the metabolomics market is classified into oncology, neurology, cardiology, and others. The market is further divided into four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). These regions are further analyzed at the country level. The research report discusses about the key market drivers, restraints, and opportunities of the global market and its submarkets.

In 2013, the high performance liquid chromatography (HPLC) segment commanded the largest share of the global metabolomics market. The large share of the HPLC segment can be attributed to its wide application in biomarker discovery. The HPLC segment will continue to dominate this market by 2019, growing at a moderate CAGR during the forecast period. Furthermore, the rising demand for personalized medicine and increased necessity for toxicology testing are also expected to drive the growth of the market.

North America accounts for the largest share to the global market, followed by Europe, Asia-Pacific, and RoW. The European region is expected to grow at the highest CAGR during the forecast period, largely driven by the increasing research funding form governments and private investors and growing demand for personalized medicine.

The major players in the market include Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), Agilent Technologies (U.S.), Metabolon, Inc. (U.S.), Shimadzu Corporation (Japan), Bruker Corporation (U.S.), and Biocrates Life Sciences AG. (Austria).

Metabolomics Market, by Technique (2014 -2019)

Metabolomics Market

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports